HEPATITIS-B VIRUS ERADICATION STRATEGY FOR ASIA

被引:29
|
作者
SUNG, JL
机构
[1] Department of Internal Medicine, College of Medicine, National Taiwan University Hospital, Taipei
关键词
Asia; cost-benefit analysis; Expanded Programme on Immunization; Hepatitis B virus; hepatocellular carcinoma; Pacific;
D O I
10.1016/0264-410X(90)90227-D
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The prevalence of hepatitis B virus (HBV) infection and its sequelae vary widely in the different populations living in the Asian-Pacific region. Horizontal transmission plays an important role in the spread of the disease; in East Asia, however, maternal transmission is particularly significant since a high portion of infected infants become chronic carriers and develop cirrhosis and hepatocellular carcinoma later in life. Cost-benefit studies performed in Taipei and Shanghai show that hepatitis B vaccination is cost-effective. The three main strategies for HBV eradication include universal immunization or active plus passive immunization in areas of high endemicity, and selective vaccination of high-risk groups where carriage of the surface antigen is low. © 1990.
引用
收藏
页码:S95 / S99
页数:5
相关论文
共 50 条
  • [31] REACTIVATION OF HEPATITIS-B VIRUS
    不详
    LANCET, 1977, 1 (8011): : 578 - 580
  • [32] ONCOGENICITY OF HEPATITIS-B VIRUS
    KOSHY, R
    MEYER, M
    REVIEWS IN MEDICAL VIROLOGY, 1992, 2 (03) : 131 - 140
  • [33] MYOCARDITIS AND HEPATITIS-B VIRUS
    MAHAPATRA, RK
    ELLIS, GH
    ANGIOLOGY, 1985, 36 (02) : 116 - 119
  • [34] CONTROL OF HEPATITIS-B VIRUS
    FELMAR, E
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 233 (02): : 138 - 138
  • [35] GROWING HEPATITIS-B VIRUS
    不详
    NATURE, 1974, 247 (5438) : 176 - 177
  • [36] HEPATITIS-B VIRUS IMMUNOPATHOGENESIS
    CHISARI, FV
    FERRARI, C
    ANNUAL REVIEW OF IMMUNOLOGY, 1995, 13 : 29 - 60
  • [37] HEPATITIS-B VIRUS AND MYOCARDITIS
    URSELL, PC
    HABIB, A
    SHARMA, P
    MESATEJADA, R
    LEFKOWITCH, JH
    FENOGLIO, JJ
    HUMAN PATHOLOGY, 1984, 15 (05) : 481 - 484
  • [38] IMMUNOLOGY OF HEPATITIS-B VIRUS
    RUEFF, B
    REVUE DU PRATICIEN, 1986, 36 (14): : 774 - 775
  • [39] HEPATITIS-B VIRUS AND HEPATOCARCINOMA
    TIOLLAIS, P
    DEJEAN, A
    BUENDIA, MA
    M S-MEDECINE SCIENCES, 1990, 6 (02): : 96 - 97
  • [40] ONCOGENICITY OF THE HEPATITIS-B VIRUS
    HOBOM, B
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1980, 122 (48): : 1708 - 1708